EXO Exova Grp

TIDMEXO

RNS Number : 9856P

Exova Group PLC

24 November 2016

EXOVA GROUP PLC

Notification of transactions of Directors and PDMRs

On 23 November 2016, Paul Barry, a person discharging managerial responsibilities ("PDMR"), exercised the vested portion of a bonus share award granted under the Exova Group plc Deferred Bonus Plan to acquire the number of ordinary shares of 1 pence each ("Shares") in Exova Group plc as set out below with an aggregate exercise price of GBP1.

 
   1. Name     2. Status    3. Number of Shares under 
                                 Option exercised 
------------  -----------  -------------------------- 
 Paul Barry    PDMR                            58,824 
------------  -----------  -------------------------- 
 

Following exercise, Paul Barry's total shareholding in the capital of Exova Group plc is 89,900 ordinary shares, representing 0.04 per cent. of the voting share capital of Exova Group plc.

 
 1.    Details of the person discharging managerial 
        responsibilities/person closely associated 
----  ----------------------------------------------------------- 
 a)    Name                    Paul Barry 
----  ----------------------  ----------------------------------- 
 2.    Reason for the notification 
----  ----------------------------------------------------------- 
 a)    Position/status         PDMR - Group Managing Director, 
                                Industries 
----  ----------------------  ----------------------------------- 
 b)    Initial notification    Initial notification 
        / Amendment 
----  ----------------------  ----------------------------------- 
 3.    Details of the issuer, emission allowance 
        market participant, auction platform, 
        auctioneer or auction monitor 
----  ----------------------------------------------------------- 
 a)    Name                    Exova Group plc 
----  ----------------------  ----------------------------------- 
 b)    LEI 
----  ----------------------  ----------------------------------- 
 4.    Details of the transaction(s): section 
        to be repeated for (i) each type of instrument; 
        (ii) each type of transaction; (iii) each 
        date; and (iv) each place where transactions 
        have been conducted 
----  ----------------------------------------------------------- 
 a)    Description             Ordinary shares of 1p each 
        of the financial 
        instrument,             GB00BKY7HG11 
        type of instrument 
        Identification 
        code 
----  ----------------------  ----------------------------------- 
 b)    Nature of               Acquisition of shares following 
        the transaction         exercise of bonus share award 
                                granted under the Exova Group 
                                plc Deferred Bonus Plan 
----  ----------------------  ----------------------------------- 
 c)    Price(s) and                  Price(s)          Volume(s) 
        volume(s) 
----  ----------------------  ----------------------  ----------- 
                  Aggregate exercise 
                     price of GBP1                       58,824 
  --------------------------------------------------  ----------- 
 d)    Aggregated 
        information 
        - Aggregated             N/A 
        volume 
        - Price 
----  ----------------------  ----------------------------------- 
 e)    Date of the             23 November 2016 
        transaction 
----  ----------------------  ----------------------------------- 
 f)    Place of the            London 
        transaction 
----  ----------------------  ----------------------------------- 
 

This notification is made in accordance with Article 19 of the Market Abuse Regulation and the Disclosure and Transparency Rules.

For and on behalf of Exova Group plc

Date: 24 November 2016

Neil MacLennan

General Counsel & Company Secretary

Telephone: 0131 333 8053

About Exova

Exova is one of the world's leading laboratory-based testing groups, trusted by organisations to test and advise on the safety, quality and performance of their products and operations. Headquartered in Edinburgh, UK, Exova operates 138 laboratories and offices in 33 countries and employs more than 4,300 people throughout Europe, the Americas, the Middle East, Asia/Asia Pacific and Africa.

Exova's capabilities help to extend asset life, bring predictability to applications, and shorten the time to market for customers' products, processes and materials. With over 90 years' experience, Exova specialises in testing across a number of key sectors ranging from Aerospace to Fire & Building Products; Oil & Gas and Industrials; Infrastructure & Environment; Automotive; and Health Sciences.

This information is provided by RNS

The company news service from the London Stock Exchange

END

DSHUOONRNSAAUAA

(END) Dow Jones Newswires

November 24, 2016 04:00 ET (09:00 GMT)

Exova (LSE:EXO)
Historical Stock Chart
From Mar 2024 to Apr 2024

Exova (LSE:EXO)
Historical Stock Chart
From Apr 2023 to Apr 2024